SYNARC to Attend the European Society of Cardiology (ESC) Congress

Newark, CA - July 31, 2011 - SYNARC, the world’s leading provider of medical imaging services for the pharmaceutical, biotechnology, and medical device industries, announced today that Dr. Margaret Ziola, Medical Director of Cardiology, and Dr. Peter Milner, Chairman of SYNARC’s Cardiovascular Scientific Advisory Board members will be attending the European Society of Cardiology (ESC) Congress conference in Paris from August 27th to 31st.

SYNARC has extensive expertise in cardiovascular imaging services including angiography, echocardiography, cardiac MRI, carotid intima media thickness (CIMT), intravascular ultrasound (IVUS) and other modalities to support cardiovascular clinical programs, as well as cardiac safety assessments in other therapeutic areas such as oncology and metabolic diseases.  SYNARC continues to make progress in building its cardiovascular franchise and in particular, to broaden the range of imaging modalities it offers its clients for use in clinical trials. 

“Our scientific team is engaged in discussions on advances in cardiac imaging in clinical trials, such as atherosclerotic plaque by CMR, CIMT, IVUS and PET,” said Margaret Ziola, “As we continue to add to our cardiovascular imaging capabilities, we would welcome the opportunity to discuss with clinical trial sponsors their experience with cardiac imaging to date and their future clinical program needs.”
About the European Society of Cardiology

The European Society of Cardiology (ESC) represents over 62,000 cardiology professionals worldwide. The ESC provides a wide range of scientific and educational programs and also organizes the annual ESC Congress, the largest cardiology meeting in the world. The ESC Congress provides an opportunity for cardiology professionals to meet and discuss the latest thinking in the science, management, and prevention of cardiovascular diseases.
About CCBR-SYNARC

About CCBR-SYNARC

CCBR-SYNARC’s medical image analysis, biochemical marker, and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. CCBR-SYNARC has partnered with industry leaders to bring numerous leading compounds to market across a broad spectrum of therapeutic areas.  Our services integrate critical aspects of clinical trial design and execution, from protocol design and subject recruitment to regulatory liaison on behalf of our clients.  Our expert radiologists and scientists are innovators in all aspects of medical image analysis and biochemical markers in drug development, and have pioneered many methods used in today’s clinical trials.

# # #
Media Contact:
Joy Valderrama
415 817-8919
joy.valderrama@synarc.com